Department of Health Science, National Natural Science Fundation of China, Beijing 100083, China.
J Thorac Dis. 2013 Oct;5(5):698-705. doi: 10.3978/j.issn.2072-1439.2013.10.10.
Lung cancer is one of malignant tumors with the highest morbidity and mortality in the world. At present, research of early diagnosis, treatment, prognosis, and metastasis associated biomarkers is most active. This article reviewed the research status of lung cancer biomarkers and analyzed the funding situation in the field of lung cancer markers in recent 10 years in China and abroad, to provide a reference for the future basic and clinical translational research of lung cancer biomarkers.
肺癌是世界上发病率和死亡率最高的恶性肿瘤之一。目前，对早期诊断、治疗、预后和转移相关生物标志物的研究最为活跃。本文综述了肺癌标志物的研究现状，并分析了国内外近 10 年来肺癌标志物领域的资助情况，为肺癌标志物的未来基础和临床转化研究提供参考。
